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Objective: Usually, physicians base their practice on guidelines, but recommendations on the same topic may vary across
guidelines. Given the uncertainties regarding abdominal aortic aneurysm (AAA) screening, physicians should be able to
identify systematically and transparently developed recommendations. We performed a systematic review of AAA
screening guidelines to assist physicians in their choice of recommendations.
Methods: Guidelines in English published between January 1, 2003 and February 26, 2010 were retrieved using
MEDLINE, CINAHL, the National Guideline Clearinghouse, the National Library for Health, the Canadian Medica-
tion Association Infobase, and the G-I-N International Guideline Library. Guidelines developed by national and
international medical societies from Western countries, containing recommendations on AAA screening were included.
Three reviewers independently assessed rigor of guideline development using the Appraisal of Guidelines Research and
Evaluation (AGREE) instrument. Two independent reviewers performed extraction of recommendations.
Results: Of 2415 titles identified, seven guidelines were included in this review. Three guidelines were less rigorously
developed based on AGREE scores below 40%. All seven guidelines contained a recommendation for one-time screening
of elderly men by ultrasonography to select AAAs >5.5 cm for elective surgical repair. Four guidelines, of which three
were less rigorously developed, contained disparate recommendations on screening of women and middle-aged men at
elevated risk. There was no agreement on the management of smaller AAAs.
Conclusions: Consensus exists across guidelines on one-time screening of elderly men to detect and treat AAAs >5.5 cm.
For other target groups and management of small AAAs, prediction models and cost-effectiveness analyses are needed to
provide guidance. (J Vasc Surg 2012;55:1296-1305.)
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cAbdominal aortic aneurysms (AAAs) contribute signif-
icantly to disease burden in developed countries, account-
ing for approximately 0.5% of total mortality in the United
States.1 Because rupture of an AAA is preceded by a pre-
clinical detectable phase and because accurate tests and
effective treatment are available, screening is likely to be
beneficial. A recent Cochrane systematic review, including
four screening trials, showed a significant decrease in AAA-
related mortality in asymptomatic men aged 65 to 79 years
who underwent ultrasound screening.2 A beneficial effect
on total mortality was not demonstrated and uncertainties
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1296emain regarding other target groups, the optimal screen-
ng strategy, policy toward small AAAs, cost-effectiveness,
nd psychological effects of screening.
In the United Kingdom, the National Health Service
bdominal Aortic Aneurysm Screening Program is being
ntroduced gradually with a full coverage across England
xpected byMarch 2013. In this program, men aged 65 are
nvited for a one-time ultrasound scan examination. In the
nited States, an abdominal ultrasound scan study for AAA
etection is offered as part of the one-time “Welcome to
edicare” preventive health examination. Medicare covers
AA screening for all men who turned 65 years of age and
moked at least 100 cigarettes and individuals with a family
istory of AAA.3 In many Western countries, however,
ystematic, nationwide screening programs are not imple-
ented, and decisions on screening are made on the indi-
idual level by primary care physicians. For example, in The
etherlands, systematic screening programs are only al-
owed in a research setting.4 Instead, opportunistic screen-
ng of siblings of patients with an AAA is recommended.
The purpose of guidelines is to close the gap between
he best available evidence and what physicians do in their
ractice. The usual method of disseminating and imple-
enting guidelines is rather passive, by publication in med-
cal journals or mailing to targeted professionals. This
ethod does not seem to achieve the guidelines’ aim:
hanging physicians’ behavior.5 Variations in recommen-
ations across guidelines on the same topic may cause
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Volume 55, Number 5 Ferket et al 1297physicians to lose confidence in the construction process
and validity of guidelines and lead to a further derivation
from this aim. In addition, relationships with the industry
can potentially influence choices made within guideline
development, making the validity of recommendations
even more questionable.6 Given the potential uncertainties
regarding AAA screening, physicians require recommenda-
tions that have been developed systematically and transpar-
ently.7
Our purpose was to assist physicians in their choice of
recommendations on AAA screening by a systematic review
and critical appraisal of current guidelines.
METHODS
Data sources and searches. The literature search,
used for a previous article on cardiovascular risk assess-
ment,8 was updated to identify guidelines of interest.
Briefly, MEDLINE, CINAHL, and four guideline-specific
databases: the National Guideline Clearinghouse (United
States), the National Library for Health on Guideline
Finder (United Kingdom), Canadian Medical Association
Infobase (Canada), and the G-I-N International Guideline
Library (http://www.g-i-n.net) were searched. Guidelines
published from January 1, 2003, to February 26, 2010, and
in the English language were considered. Additional guide-
lines were sought by searching websites of guideline devel-
opment organizations. See Appendix, online only, for the
exact search.
Study selection. A guideline was only considered if it
met the Institute of Medicine definition for clinical practice
guidelines. In order to meet this definition, a guideline has
to contain “systematically developed statements to assist
practitioner and patient decisions about appropriate health
care for specific clinical circumstances.” In order to meet
inclusion criteria, guidelines had to: (1) be developed on
behalf of a national or international medical specialty soci-
ety; (2) contain recommendations for an asymptomatic
population with no previous diagnosis of AAA; and (3)
originate from or apply to Western countries (eg, the
United States, Canada, Australia, New Zealand, or the
United Kingdom).
Titles and abstracts were reviewed independently by
two reviewers (B.S.F. and E.B.C.). Articles were only ex-
cluded if both reviewers agreed on the decision. Discrep-
ancies were resolved by consensus. The first author made
the final selection of articles based on full text.
Data extraction and quality assessment. Relevant
recommendations from the included guidelines were inde-
pendently extracted by two reviewers (B.S.F. and N.G).
Discrepancies were resolved by consensus. Each guideline
provided one or more relevant recommendations. Data
extracted included the reported methodology for evidence
synthesis, formulating of recommendations, consideration
of cost-effectiveness, the target population, the strategy for
delivery of the test, recommended tests, and test thresholds
for intervention and follow-up. In addition, the recom-
mendation was classified as “for,” “consider,” “not for not
against,” “insufficient evidence,” or “against.” (The quality of development of each included guideline
as determined using the “Rigor of Development” domain
f the Appraisal of Guidelines Research and Evaluation
AGREE) instrument, a seven item score.9 This score looks
t: (1) methods to search for evidence; (2) criteria for
electing the evidence; (3) methods for formulating the
ecommendations; (4) consideration of health benefits,
ide effects, and risks; (5) supporting evidence; (6) proce-
ures for external peer review; and (7) the update process.
ach item is rated on a 4-point Likert scale. Three reviewers
B.S.F., N.G., and J.J.V.) independently scored each
uideline. Additional information on development was also
xamined by these three reviewers by perusing websites of
uideline developers. For each reviewer, AGREE scores
ere calculated as a percentage using the sum of the seven
tems and the maximum possible score. Final rigor scores
ere calculated by averaging the AGREE scores from all
eviewers (see Table I, online only, for AGREE item scores
er guideline). Reproducibility of the three reviewers’ av-
rage rigor scores was measured with an intraclass correla-
ion coefficient. We ranked included guidelines according
o their average score. Editorial independence from fund-
ng body, external funding, and disclosure of relationships
ith industry by individual guideline group members were
ssessed (B.S.F.) and checked (N.G.). Discrepancies were
esolved by consensus. SRS version 4.0 (Mobius, Ottawa,
ntario, Canada), a web-based software package devel-
ped for systematic review data management, was used to
emove duplicates, store citations and track results at title,
bstract, quality assessment, and data extraction levels.
Data synthesis and analysis. We constructed a table
o compare the recommendations from the included guide-
ines. The table was divided into the following sections: (1)
ethodology of guideline development; (2) consideration
f cost-effectiveness regarding the recommendation; (3)
arget group and delivery of AAA screening; (4) tests consid-
red; and (5) thresholds for intervention and follow-up.
ESULTS
Selection and assessment of guidelines. We screened
415 guidelines for eligibility at title level, of which 416
ere included for review at abstract level (Fig 1). Of these,
even guidelines relevant to AAA screening were eligible for
ull data extraction. Table II summarizes the selected
uidelines, together with rigor scores and conflict of inter-
st results. Most guidelines (six of seven) were developed in
orth America. AGREE scores varied from 17% to 79%
ith three guidelines (Canadian Cardiovascular Society
CCS], Society for Vascular Surgery [SVS]1, and SVS2)
aving an AGREE score below the median, 40%. Repro-
ucibility of the AGREE scores by the three reviewers was
ood, with an intraclass correlation coefficient of 0.86. In
wo of the seven guidelines (American College of Cardiol-
gy [ACC], SVS2), at least one panel member declared
aving a relevant financial relationship with the industry.
one of these guidelines reported exclusion of group
embers from voting or discussions. Only one guideline
United States Preventive Services Task Force [USPSTF])
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May 20121298 Ferket et alcontained a statement of being developed independently
from the funding organization. Two guidelines (National
Screening Committee [NSC] and CCS) neither reported
that they were developed independently from funding or-
ganization(s), nor did they report a statement about con-
flicts of interest of group members. The seven included
guidelines contained 12 recommendations on AAA screen-
ing (Table III). Two (USPSTF and ACC) of the seven
guidelines were developed on the basis of a systematic
review of the medical literature. The remaining five
guidelines were developed using a non-systematic selec-
tion of previously developed systematic reviews or pri-
mary research. Evaluation of cost-effectiveness of AAA
screening strategies was done in six of seven guidelines
Fig 1. Literature search and selection. Numbers of guidelines of
each step of the process are indicated. Group totals may exceed the
reported numbers for the excluded articles at abstract and full text
level because several reasons for exclusion were allowed. AAA,
Abdominal aortic aneurysm;CMA,CanadianMedical Association;
NGC, National Guideline Clearinghouse.by reviewing existing decision modeling studies. sAreas of agreement and disagreement among
ecommendations. All guidelines contained at least one
ecommendation that supported AAA screening in elderly
en. Although guideline groups (six of seven) generally
greed on the age at which screening should be started
n elderly men (that is 65 years of age), they disagreed on
hether a smoking history should be present or not. In
ecommendations from two (USPSTF andACC) of the seven
uidelines, ever smoking (current or past smoking) was re-
uired. In the other five guidelines, screening was recom-
ended for elderly men regardless of smoking habits.
Three guidelines (USPSTF, ACC, and NSC) only con-
ained recommendations for AAA screening in elderly men
r recommended explicitly against screening women.
hese three guidelines had the highest AGREE scores.
uidelines with lower AGREE scores also contained rec-
mmendations for other target groups. Four guideline
roups (Canadian Society for Vascular Surgery [CSVS],
CS, SVS1, and SVS2) recommended screening in women
f risk factors for development of AAA were present. Al-
hough in two of these guidelines (CSVS and CCS) multi-
le risk factors were required, in two guidelines (SVS1 and
VS2) the presence of one risk factor was considered suffi-
ient reason to screen. Three guidelines (CCS, SVS1, and
VS2) recommended screening of middle-aged men (that
s 50 or 55 years) if a family history of AAA is present.
lthough not all guideline groups reported an age criterion
hen screening should no longer be offered, in most
uidelines (four of seven) 75 years of age was considered as
he upper age limit.
Abdominal ultrasonography was unanimously advo-
ated as the primary screening test and only one guideline
roup (ACC) recommended physical examination as a use-
ul screening tool in addition to ultrasonography. All
uideline groups recommended elective surgical repair at
n abdominal aortic diameter of 5.5 cm in elderly men.
ome guideline groups advocated using a lower threshold
ie, 5.0 cm) for women (CCS and SVS2) or young healthy
atients (SVS2) as an indication for surgical repair.
Except for the USPSTF guideline, all guidelines con-
ained recommendations for surveillance of those with an-
urysms smaller than 5.5 cm in diameter. These recommen-
ations, however, varied across the guidelines with respect
o the intensity of follow-up and aorta diameter cutoff
alues for the monitoring intervals. The two Canadian
uideline groups (CSVS and CCS) were unique in recom-
ending periodic rescreening for individuals with abdom-
nal aortic diameters below 3 cm; the remaining guideline
roups recommended one-time screening.
ISCUSSION
In summary, we identified seven guidelines on AAA
creening. A majority of guidelines lacked a systematic
ethod for the evaluation of the evidence or achieved a low
GREE score for rigor of development. Most guidelines
ontained recommendations that were in favor of one-time
AA screening for men 65 years and older using ultra-
onography scans. Four guidelines, of which three had low
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Volume 55, Number 5 Ferket et al 1299AGREE scores, also contained disparate recommendations
on screening women and middle-aged men at elevated risk,
whereas guidelines with higher AGREE scores did not.
Although an abdominal aortic diameter of 5.5 cm was
unanimously used as criterion for elective surgical repair in
elderly men, no consensus existed on management of
smaller AAAs.
A previously published review already summarized and
discussed a selection of three guidelines on AAA screening,
but the review was neither systematic nor were the selected
guidelines appraised on quality.10 We used a sensitive
search strategy to identify guidelines and we assessed the
included guidelines by a validated tool, the AGREE instru-
ment. Our article can also have additive value to guideline
summaries provided by the National Guideline Clearing-
house, as this database has only summarized some of the
guidelines that we reviewed, and does not appraise guide-
lines on quality of development.11We tried to create aware-
ness of differences across guidelines from Western coun-
tries, which generally have a comparable population health
status and access to medical resources.12 The differences,
which we identified, can have major implications for clinical
practice. Because most guidelines were produced by North
American organizations, this report is most valuable to
guide physicians from this region in choosing which rec-
ommendations to follow. Physicians may decide based on
AGREE scores and their specific clinical context which
recommendations to adopt or to avert.
Despite these strengths, we have to face certain limita-
tions of our review. First, we neither evaluated the source
nor the quality of the underlying evidence that supported
the recommendations, but instead assessed the guidelines’
construction processes. For example, disparate evidence
cited by guideline developers could provide possible causes
for variation in recommendations. Transparent develop-
ment methods and complete information on how judg-
ments were made increase the reliability of recommenda-
tions and allow physicians to make more informed
decisions on adopting them. Which recommendations
Table II. Characteristics of seven guidelines on AAA scree
Guideline,
yearReference
Organization(s) responsible for
guideline development
USPSTF, 200529 U.S. Preventive Services Task Force U
ACC, 200530 American College of Cardiology, and
American Heart Association
U
NSC, 200731 National Screening Committee U
CSVS, 200732 Canadian Society for Vascular Surgery C
CCS, 200533 Canadian Cardiovascular Society C
SVS2, 200934 Society for Vascular Surgery U
SVS1, 200435 Society for Vascular Surgery,
American Association of Vascular
Surgery, and Society for Vascular
Medicine and Biology
U
AAA, Abdominal aortic aneurysm; AGREE, Appraisal of Guidelines Resea
conflicts of interest of group members present.
aRelationship with industry reported by any group member.would result in better outcomes can be determined in comparative effectiveness research,13 but this was beyond
he scope of our review. Second, the AGREE instrument
nly considers the details of reporting information related
o the development of the guideline. The true quality of the
uideline can, therefore, not be fully captured. For exam-
le, a guideline group which performs a systematic search
or evidence and which does not report detailed informa-
ion on the search strategy followed, will receive a low
GREE score for this item. In reality, the search followed
ay be adequate for identifying solid evidence. Although
e did search the organization’s website for additional
ackground information, we did not contact guideline
evelopers for additional information that was lacking in
he guideline document or on the website. Third, the
GREE instrument provides a quality score on a linear
cale. This means that each item is weighed equally. We
elieve that all items of the AGREE Rigor of Development
omain are relevant, supporting equal weighting across
tems. The contribution of each individual item to the total
uality of a guideline is, however, difficult to assess. Fourth,
t was difficult to quantify the true degree of influence by
ndustry relationships. We had to rely on the disclosures
hat were believed to be relevant for decision-making by
roup members themselves. We also could not assess the
ize of entanglements with industry, because guidelines did
ot report the payment amounts received.
Although all guidelines agreed upon screening elderly
en, some guidelines advocated a more selective screening
egime based on smoking history. Selective screening in-
tead of whole population screening could result in too
any missed AAAs.14 Nevertheless, a modeling study
howed that selective screening of men aged 65 to 75 years
ho have ever smoked, as recommended by the USPSTF
nd ACC, did not severely affect the detection rate.15
sing ever-smoking as a preselection tool, however, poten-
ially has the disadvantage that ever-smoking not only acts
n prevalence of AAA, but also on comorbidities.16 The
xpected gain in life years by AAA screening could then be
ullified by the raised competing risk due to other death
try that guideline
applies to AGREE rigor score Conflicts of interest
States of America 79% EI
States of America 63% SCIa
Kingdom 41% —
40% SCI
38% —
States of America 25% SCIa
States of America 17% SCI
d Evaluation; EI, editorial independence declared; SCI, statement aboutning
Coun
nited
nited
nited
anada
anada
nited
nited
rch anauses. This was not taken into account for calculation of
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May 20121300 Ferket et alTable III. Recommendations (n  12) in guidelines (n  7) on screening for abdominal aortic aneurysm
USPSTF USPSTF USPSTF ACC NSC
AGREE rigor score 79% 79% 79% 63% 41%
Method to evaluate
evidence
Meta-analysis;
systematic
review
Meta-analysis;
systematic
review
Meta-analysis;
systematic
review
Systematic review Review of published
systematic reviews,
meta-analyses or
guidelines;
review
Method to
formulate
recommendations
Expert consensus Expert consensus Expert consensus Expert consensus Expert consensus
Consideration of
costs
Systematic review
of cost-
effectiveness
studies
Systematic review
of cost-
effectiveness
studies
Systematic review
of cost-
effectiveness
studies
Review of cost-effectiveness
studies
Review of cost-
effectiveness studies
Target group Men aged 65-75
years who have
ever smokeda
Men aged 65-75
years who have
never smoked
Women Men aged 60 years who
are siblings or offspring of
patients with AAAs; men
aged 65-75 years who ever
smokeda
Men aged 65 years
Strategy Opportunistic
screening/case-
finding
Opportunistic
screening/case-
finding
Opportunistic
screening/case-
finding
Not reported Population-based/
mass screening
Recommendation For Not for not
against
Against For For
Primary screening
tests
Abdominal
ultrasonography
Abdominal
ultrasonography
Abdominal
ultrasonography
Abdominal ultrasonography;
physical examination
Abdominal
ultrasonography
Intervention(s) Endovascular
repair or open
surgical repair
if AAA5.5 cm
Endovascular
repair or open
surgical repair
if AAA5.5 cm
Endovascular
repair or open
surgical repair
if AAA5.5 cm
Surgical repair if infrarenal or
juxtarenal AAAs 5.5 cm
(repair is probably
indicated in patients with
suprarenal or type IV
thoracoabdominal aortic
aneurysms 5.5-6.0 cm);
no intervention if
infrarenal or juxtarenal
AAAs 4.0-5.4 cm, but
repair can be beneficial in
patients with infrarenal or
juxtarenal AAAs 5.0-5.4 cm
Referral to a vascular
surgeon if AAA
5.5 cm
Surveillance Not reported Not reported Not reported Monitoring by ultrasound or
computed tomographic
scans every 6-12 months
to detect expansion if
infrarenal or juxtarenal
AAAs 4.0-5.4 cm;
monitoring by ultrasound
examination every 2-3
years is reasonable if AAAs
smaller than 4.0 cm in
diameter
A follow-up will be
arranged in 3
months if AAA 4.5-
5.4 cm; a follow-up
will be arranged in
one year if AAA
measures 3.0-4.4 cm
Screening intervals One-time
screening
One-time
screening
One-time
screening
One-time screening if not in
above categories
One-time screening if
not in above
categories
CSVS CSVS CSVS CSVS
AGREE rigor score 40% 40% 40% 40%
Method to evaluate
evidence
Review of published
systematic reviews,
meta-analyses or
guidelines; review
Review of published
systematic reviews,
meta-analyses or
guidelines; review
Review of published
systematic reviews,
meta-analyses or
guidelines; review
Review of published
systematic reviews,
meta-analyses or
guidelines; review
Method to
formulate
Expert consensus Expert consensus Expert consensus Expert consensusrecommendations
JOURNAL OF VASCULAR SURGERY
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CSVS CSVS CSVS CSVS
Consideration of
costs
Review of cost-effectiveness
studies and published
systematic review of
cost-effectiveness
studies; cost-
effectiveness analysis
using projection of real
cost data
Review of cost-effectiveness
studies and published
systematic review of
cost-effectiveness
studies; cost-
effectiveness analysis
using projection of real
cost data
Review of cost-effectiveness
studies and published
systematic review of
cost-effectiveness
studies; cost-
effectiveness analysis
using projection of real
cost data
Review of cost-effectiveness
studies and published
systematic review of
cost-effectiveness
studies; cost-
effectiveness analysis
using projection of real
cost data
Target group Men aged 65-75 years
who are candidates for
surgery and are willing
to participate
Women aged 65 years
and multiple RFsb
Women aged 65 years,
adult population aged
65 years
Deducted from text: men
aged 75 years and
multiple RFsb
Strategy Population-based/mass
screening
Individualized
investigation
Population-based/mass
screening
Individualized
investigation
Recommendation For Consider Against Consider
Primary screening
tests
Abdominal
ultrasonography
Abdominal
ultrasonography
Abdominal
ultrasonography
Abdominal
ultrasonography
Intervention(s) Deducted from text:
surgical repair at
5.5 cm
Deducted from text:
surgical repair at
5.5 cm
Deducted from text:
surgical repair at
5.5 cm
Deducted from text:
surgical repair at
5.5 cm
Surveillance Policy not clearly
described in guideline if
AAA 4.4-5.4 cm; an
annual abdominal
ultrasound is an
acceptable practice if
AAA 3.0-4.4 cm. The
true effective interval of
rescreening is unknown
for this group and it is
likely that every 2 years
is also acceptable for the
smaller aneurysms
Policy not clearly
described in guideline if
AAA 4.4-5.4 cm; an
annual abdominal
ultrasound is an
acceptable practice if
AAA 3.0-4.4 cm. The
true effective interval of
rescreening is unknown
for this group and it is
likely that every 2 years
is also acceptable for the
smaller aneurysms
Policy not clearly
described in guideline if
AAA 4.4-5.4 cm; an
annual abdominal
ultrasound is an
acceptable practice if
AAA 3.0-4.4 cm. The
true effective interval of
rescreening is unknown
for this group and it is
likely that every 2 years
is also acceptable for the
smaller aneurysms
Policy not clearly
described in guideline if
AAA 4.4-5.4 cm; an
annual abdominal
ultrasound is an
acceptable practice if
AAA 3.0-4.4 cm. The
true effective interval of
rescreening is unknown
for this group and it is
likely that every 2 years
is also acceptable for the
smaller aneurysms
Screening intervals No follow-up ultrasound
is necessary before 3-5
years if aortic diameter
3.0 cm
No follow-up ultrasound
is necessary before 3-5
years if aortic diameter
3.0 cm
No follow-up ultrasound
is necessary before 3-5
years if aortic diameter
3.0 cm
No follow-up ultrasound
is necessary before 3-5
years if aortic diameter
3.0 cm
CCS SVS2 SVS1
AGREE rigor score 38% 25% 17%
Method to evaluate
evidence
Review Review Review
Method to formulate
recommendations
Expert consensus Expert consensus Expert consensus
Consideration of costs Review of cost-effectiveness studies Review of cost-effectiveness studies,
but not for AAA screening
Review of cost-effectiveness studies
Target group Men aged 65-74 years; women aged
65 years with cardiovascular disease
and positive family history of
AAA; men aged 50 years and
positive family history of AAA
Men aged 65 years; men aged
55 years and family history of
AAA; women aged 65 years
and family history of AAA or
who have smoked
Men aged 60-85 years; women aged
60-85 years and cardiovascular risk
factors (not specified); men and
women aged 50 years and
family history of AAA
Strategy Population-based/mass screening Population-based/mass screening Population-based/mass screening
Recommendation For For For
Primary screening tests Abdominal ultrasonography Abdominal ultrasonography Abdominal ultrasonography
Intervention(s) Referral to vascular surgeon if AAA
4.5 cm; surgical repair if men
AAA 5.5 cm and if women
AAA 5.0 cm; consider surgical
repair if 1-cm growth in 1 year
Surgical repair if fusiform AAA
5.5 cm, saccular AAA,c young
healthy patients, and especially
women, with AAA 5.0-5.4 cmc;
statins,c smoking cessation, ACE
inhibitors/angiotensin receptor
blockersc if surveillance (AAA
3.5-5.4 cm: not clearly
Referral to a vascular specialist if
AAA 4.5 cm; surgical repair if
5.5 cm: policy not clearly
describeddescribed)
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modeling study.15 Other guideline groups recommended
screening also in populations other than men aged 65 to 75
years if risk factors are present (eg, men aged 50 to 65 years,
men older than 75 years, and women). For these popula-
tions, no clear evidence exists from experimental research
for such a recommendation.2 The reasoning is that the risk
of having an AAA is markedly increased if risk factors are
present. The odds ratio, however, generally needs to be
high before a risk factor can be used for risk classification.17
The odds ratios of single risk factors other than smoking are
low for clinically relevant large AAAs.14,18 Therefore, com-
bining risk factors may be warranted to avoid unnecessary
ultrasonographies and over-diagnosis of small AAAs for
which the optimal treatment strategy is unclear.19,20 On
the other hand, when screening is recommended both at a
younger age if risk factors are present and at an older age
regardless of risk factors, such as in ACC, CCS, SVS1, and
SVS2 guidelines, then a bias similar to lead time bias could
occur. Only the AAAs that are vulnerable to rupture in the
short term contribute to benefit of screening at an earlier
age. Slowly growing AAAs would most likely be identified
at the older screening age. The additional benefit of screen-
ing in middle-aged men and women at elevated risk can be
explored by comparing the different screening strategies in
a decision analysis.
The variation in recommendations for policy toward
small asymptomatic AAAs is relevant because with screen-
ing approximately 90% of the detected AAAs will be smaller
than 5.5 cm in diameter.18,21 Two guideline groups (CCS
and SVS2) suggested using smaller diameters for women
and healthy young patients as the threshold for elective
surgical repair. Two meta-analyses did not show an im-
provement of overall survival in the immediate surgical
repair group as compared to those allocated to surveil-
lance.19,20 There was insufficient power to identify sub-
Table III. Continued
CCS
Surveillance Repeat ultrasound every 6 months
if AAA 4.5 cm; repeat
ultrasound in 1 year if AAA 4.0-
4.5 cm; repeat ultrasound in 2
year if AAA 3.5-3.9 cm; repeat
ultrasound in 3 years if AAA 3.1-
3.4 cm
Rep
if
u
4
y
u
2
Screening intervals Repeat ultrasound follow-up in 3-5
years if aortic diameter 3.0 cm
On
d
o
a
5
AAA, Abdominal aortic aneurysm; ACC, American College of Cardiolog
Cardiovascular Society; CSVS, Canadian Society for Vascular Surgery; NS
Surgery; USPSTF, United States Preventive Services Task Force.
aPast or current smokers.
bFamily history of AAA, smoking history, cerebrovascular disease, age 70
cLevel of recommendation is weak, or benefit is uncertain.groups that might benefit from immediate repair. A recent Mublished trial not included in the two meta-analyses also
id not demonstrate a benefit on overall mortality after
mmediate endovascular repair, although this trial was
topped earlier because the event rate of the primary out-
ome measure of rupture or aneurysm-related death was
oo low to achieve sufficient statistical power.22 According
o the Cochrane review,20 an individual patient-level data
eta-analysis is under way to conduct subgroup analyses,
hich are expected to elucidate risks and benefits of each
reatment option for aneurysm size subgroups, and age
ubgroups (for example 69 years, and 69 years). Mul-
ivariable prediction models of rupture and operative risk
ould also be used to identify those expected to benefit
rom immediate surgical repair. Multiple predictors deter-
ine rupture23,24 and operative risk25 and, therefore, vari-
tion in treatment effect is difficult to be captured by single
atient characteristics. The use of prediction models for
upture risk and operative risks has the advantage that
redictors that influence both, for example, female gen-
er,26 can be taken into account. A combination of a
igh-predicted rupture risk and a low-predicted operative
isk is then likely to result in a survival benefit from imme-
iate surgical repair. In the absence of experimental evi-
ence for a survival benefit, the trade-off between immedi-
te surgical repair and surveillance can be based on costs
nd quality of life by using decision modeling and cost-
ffectiveness analyses. In addition, the optimal screening
nd monitoring intervals can then be evaluated.
Although methods are available for integrating various
ecommendations into a single guideline, our purpose was
ot to create a new “universal” AAA screening guideline.
owever, a summarizing screening algorithm comprising
he recommendations that the guidelines had in common
nd our suggestions for future research is depicted in Fig 2.
he actual implementation of these recommendations in
rimary care is critical in optimizing patient outcomes.
SVS2 SVS1
ltrasound every 6 months
4.5-5.4 cm; repeat
und in 1 year if AAA 3.5-
; repeat ultrasound in 3
f AAA 3.0-3.4 cm; repeat
und in 5 years if AAA 2.6-
Repeat ultrasound every 6 months
if AAA 4.0-4.5 cm; annual
ultrasound examination if AAA
3.0-4.0 cm
e screening if aortic
ter 2.6 cm and 65 years
or older; not reported if
diameter 2.6 cm and age
years of age
One time screening if aortic
diameter 3.0 cm
REE, Appraisal of Guidelines Research and Evaluation; CCS, Canadian
tional Screening Committee; RFs, risk factors; SVS, Society for Vascular
old.eat u
AAA
ltraso
.4 cm
ears i
ltraso
.9 cm
e tim
iame
f age
ortic
5-65
y; AG
C, Naethods to measure and improve the delivery and adher-
11
1
1
1
lysis.
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Volume 55, Number 5 Ferket et al 1303ence of AAA screening interventions are, for example,
performance measures and decision support systems, but
these are still topics for further research.27,28
CONCLUSIONS
Consensus exists across guidelines on one-time screen-
ing of elderly men to detect and treat AAAs 5.5 cm. For
strategies toward other target groups, and management of
small AAAs, prediction models and cost-effectiveness anal-
yses are needed to provide guidance.
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t www.jvascsurg.org.INVITED COMMENTARYElliot L. Chaikof, MD, PhD, Boston, Mass
Clinical practice guidelines for the care of a patient with an
abdominal aortic aneurysm (AAA) have been published from a variety
of sources, including disparate specialty groups and government-
sponsored organizations. Although each published guideline is the
end result of a comprehensive review of the available clinical
evidence, recommendations are often not uniform. In large mea-
sure, this reflects a reality in which the evidence for many clinical
decisions is lacking or of limited quality and simple rules for
weighing the validity of any individual randomized controlled trial
or observational study do not exist. As such, expert panels are
called upon to assess the available evidence and provide consensus
recommendations. Cognitive biases and differences in values are
inherent in any set of recommendations, particularly in efforts
directed at averting loss of life, weighing the risks and benefits of
intervention, and optimizing cost-effective care. Limiting bias,
improving the quality of decisions, and enhancing forecasts in a
world where information is incomplete is an area of active investi-ng of Recommendations, Assessment, Development and Evalua-
ion (GRADE) system was introduced to note the strength of any
iven recommendation, as well as the quality of the available
vidence. Although these and other tools have some value in
etermining whether a practitioner should adopt a specific guide-
ine, the burden to carefully evaluate both the stated rationale and
he related content that forms the basis for the recommendation
emains on the clinician. For many areas, particularly where the
ata may be incomplete, this requires a measure of effort and an
ppreciation of the unique context of one’s practice.
Recently, academicians from the field of public health and
pidemiology, largely from the UK, The Netherlands, and Canada
ave offered to ease the cognitive burden of primary care providers
nd government policy makers when presented with varying prac-
ice guidelines through the introduction of a new instrument, the
ppraisal of Guidelines, REsearch and Evaluation (AGREE) tool.
his tool has been designed to assess the process of guideline
evelopment and how well this process is reported, as the primary
eans of appraising the quality of clinical practice guidelines. The
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review
Update
process
Domain
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